These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 20399237)
1. TM4SF5 accelerates G1/S phase progression via cytosolic p27Kip1 expression and RhoA activity. Kim H; Kang M; Lee SA; Kwak TK; Jung O; Lee HJ; Kim SH; Lee JW Biochim Biophys Acta; 2010 Aug; 1803(8):975-82. PubMed ID: 20399237 [TBL] [Abstract][Full Text] [Related]
2. Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma. Lee SA; Lee SY; Cho IH; Oh MA; Kang ES; Kim YB; Seo WD; Choi S; Nam JO; Tamamori-Adachi M; Kitajima S; Ye SK; Kim S; Hwang YJ; Kim IS; Park KH; Lee JW J Clin Invest; 2008 Apr; 118(4):1354-66. PubMed ID: 18357344 [TBL] [Abstract][Full Text] [Related]
3. Gefitinib resistance of cancer cells correlated with TM4SF5-mediated epithelial-mesenchymal transition. Lee MS; Kim HP; Kim TY; Lee JW Biochim Biophys Acta; 2012 Feb; 1823(2):514-23. PubMed ID: 22178131 [TBL] [Abstract][Full Text] [Related]
4. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors. Zhang S; Tang Q; Xu F; Xue Y; Zhen Z; Deng Y; Liu M; Chen J; Liu S; Qiu M; Liao Z; Li Z; Luo D; Shi F; Zheng Y; Bi F Mol Cancer Res; 2009 Apr; 7(4):570-80. PubMed ID: 19372585 [TBL] [Abstract][Full Text] [Related]
5. Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression. Grillo M; Bott MJ; Khandke N; McGinnis JP; Miranda M; Meyyappan M; Rosfjord EC; Rabindran SK Breast Cancer Res Treat; 2006 Jan; 95(2):185-94. PubMed ID: 16319987 [TBL] [Abstract][Full Text] [Related]
6. Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells. Ni HJ; Chang YN; Kao PH; Chai SP; Hsieh YH; Wang DH; Fong JC Biochim Biophys Acta; 2012 Dec; 1820(12):1893-900. PubMed ID: 22906975 [TBL] [Abstract][Full Text] [Related]
7. JNK signaling activity regulates cell-cell adhesions via TM4SF5-mediated p27(Kip1) phosphorylation. Kim H; Jung O; Kang M; Lee MS; Jeong D; Ryu J; Ko Y; Choi YJ; Lee JW Cancer Lett; 2012 Jan; 314(2):198-205. PubMed ID: 22014979 [TBL] [Abstract][Full Text] [Related]
8. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway. Li A; Wang J; Wu M; Zhang X; Zhang H Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792 [TBL] [Abstract][Full Text] [Related]
9. p27kip1 Regulates cdk2 activity in the proliferating zone of the mouse intestinal epithelium: potential role in neoplasia. Smartt HJ; Guilmeau S; Nasser SV; Nicholas C; Bancroft L; Simpson SA; Yeh N; Yang W; Mariadason JM; Koff A; Augenlicht LH Gastroenterology; 2007 Jul; 133(1):232-43. PubMed ID: 17631145 [TBL] [Abstract][Full Text] [Related]
10. ClC-3 Chloride Channel Proteins Regulate the Cell Cycle by Up-regulating cyclin D1-CDK4/6 through Suppressing p21/p27 Expression in Nasopharyngeal Carcinoma Cells. Ye D; Luo H; Lai Z; Zou L; Zhu L; Mao J; Jacob T; Ye W; Wang L; Chen L Sci Rep; 2016 Jul; 6():30276. PubMed ID: 27451945 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL; Buffolino P; Kopman C; Nathanson L Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260 [TBL] [Abstract][Full Text] [Related]
12. The Rho GTPase effector ROCK regulates cyclin A, cyclin D1, and p27Kip1 levels by distinct mechanisms. Croft DR; Olson MF Mol Cell Biol; 2006 Jun; 26(12):4612-27. PubMed ID: 16738326 [TBL] [Abstract][Full Text] [Related]
13. Requirement of ClC-3 in G0/G1 to S Phase Transition Induced by IGF-1 via ERK1/2-Cyclins Cascade in Multiple Myeloma Cells. Du Y; Tu YS; Tang YB; Huang YY; Zhou FM; Tian T; Li XY Clin Lab; 2018 Jun; 64(6):929-936. PubMed ID: 29945325 [TBL] [Abstract][Full Text] [Related]
14. ERK activity and G1 phase progression: identifying dispensable versus essential activities and primary versus secondary targets. Villanueva J; Yung Y; Walker JL; Assoian RK Mol Biol Cell; 2007 Apr; 18(4):1457-63. PubMed ID: 17314399 [TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 regulates p27(Kip1) stability in B cells. Bustany S; Tchakarska G; Sola B Cell Signal; 2011 Jan; 23(1):171-9. PubMed ID: 20837141 [TBL] [Abstract][Full Text] [Related]
16. Id3 is a novel regulator of p27kip1 mRNA in early G1 phase and is required for cell-cycle progression. Chassot AA; Turchi L; Virolle T; Fitsialos G; Batoz M; Deckert M; Dulic V; Meneguzzi G; BuscĂ R; Ponzio G Oncogene; 2007 Aug; 26(39):5772-83. PubMed ID: 17404577 [TBL] [Abstract][Full Text] [Related]
17. Regulated expression of cofilin and the consequent regulation of p27(kip1) are essential for G(1) phase progression. Tsai CH; Chiu SJ; Liu CC; Sheu TJ; Hsieh CH; Keng PC; Lee YJ Cell Cycle; 2009 Aug; 8(15):2365-74. PubMed ID: 19556892 [TBL] [Abstract][Full Text] [Related]